Your browser doesn't support javascript.
loading
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model.
Imbrechts, Maya; Maes, Wim; Ampofo, Louanne; Van den Berghe, Nathalie; Calcoen, Bas; Van Looveren, Dominique; Kerstens, Winnie; Rasulova, Madina; Vercruysse, Thomas; Noppen, Sam; Abdelnabi, Rana; Foo, Caroline; Hollevoet, Kevin; Maes, Piet; Zhang, Xin; Jochmans, Dirk; Ven, Karen; Lammertyn, Jeroen; Vanhoorelbeke, Karen; Callewaert, Nico; De Munter, Paul; Schols, Dominique; Thibaut, Hendrik Jan; Neyts, Johan; Declerck, Paul; Geukens, Nick.
  • Imbrechts M; KU Leuven, PharmAbs: the KU Leuven Antibody Center, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • Maes W; KU Leuven, Department Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, 3000 Leuven, Belgium.
  • Ampofo L; KU Leuven, MabMine: KU Leuven Single B Cell Mining Platform, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • Van den Berghe N; KU Leuven, PharmAbs: the KU Leuven Antibody Center, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • Calcoen B; KU Leuven, MabMine: KU Leuven Single B Cell Mining Platform, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • Van Looveren D; KU Leuven Campus Kortrijk, IRF Life Sciences, Laboratory for Thrombosis Research, 3000 Leuven, Belgium.
  • Kerstens W; KU Leuven, PharmAbs: the KU Leuven Antibody Center, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • Rasulova M; KU Leuven, MabMine: KU Leuven Single B Cell Mining Platform, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • Vercruysse T; KU Leuven, Department Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, 3000 Leuven, Belgium.
  • Noppen S; KU Leuven Campus Kortrijk, IRF Life Sciences, Laboratory for Thrombosis Research, 3000 Leuven, Belgium.
  • Abdelnabi R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), KU Leuven, Leuven, Belgium.
  • Foo C; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), KU Leuven, Leuven, Belgium.
  • Hollevoet K; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), KU Leuven, Leuven, Belgium.
  • Maes P; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), KU Leuven, Leuven, Belgium.
  • Zhang X; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.
  • Jochmans D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.
  • Ven K; GVN, Global Virus Network.
  • Lammertyn J; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.
  • Vanhoorelbeke K; GVN, Global Virus Network.
  • Callewaert N; KU Leuven, PharmAbs: the KU Leuven Antibody Center, Herestraat 49 box 820, 3000 Leuven, Belgium.
  • De Munter P; KU Leuven, Department Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, 3000 Leuven, Belgium.
  • Schols D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.
  • Thibaut HJ; GVN, Global Virus Network.
  • Neyts J; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.
  • Declerck P; GVN, Global Virus Network.
  • Geukens N; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.
iScience ; 25(8): 104705, 2022 Aug 19.
Article en En | MEDLINE | ID: mdl-35813873
Palabras clave